Block listing Interim Review

RNS Number : 5589O

AstraZeneca PLC

01 June 2020

 

1 June 2020 15:00 BST

Block Listing Six Monthly Return

Information provided on this form must be typed or printed electronically and provided to an ris.

Date: 1 June 2020

Name of applicant:		ASTRAZENECA PLC
Name of scheme:		ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS-RELATED SHARE OPTION PLAN; ASTRAZENECA ALL-EMPLOYEE SHARE PLAN; ASTRAZENECA PLC 2012 SAVINGS-RELATED SHARE OPTION SCHEME
Period of return:	From:	1 December 2019	To:	31 May 2020
Balance of unallotted securities under scheme(s) from previous return:		1,111,666
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		348,131
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		763,535

Name of contact:	CAMILLA JOHNSTONE
Telephone number of contact:	020 3749 5000

AstraZeneca

AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @ AstraZeneca .

Contacts

For details on how to contact the Investor Relations Team, please click here . For Media contacts, click here .

Adrian Kemp
Company Secretary

AstraZeneca PLC

 

END

 

 

BLRSSAFFFESSEFM